Taiwan Bio Therapeutics Co., Ltd (6892.TWO)

TWD 38.9

(-0.13%)

Market Cap (In TWD)

2.9 Billion

Revenue (In TWD)

85.47 Million

Net Income (In TWD)

-217.51 Million

Avg. Volume

295.68 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
32.6-60.1
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006892003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
-
Employee Count
-
Website
https://www.twbio-thera.com
Ipo Date
2022-09-08
Details
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei City, Taiwan.